SAM#7962
A - Research and Development
SAMDaily.us: AWARDS - September 15, 2023
- 75N93023C00048 - 6394915.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
INSTITUT DE FORMULATION DES VACCINS (CH) SA Plan-les-ouates 1228 CHE
- 75N93023C00047 - 12331199.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
UNIVERSITY OF MONTANA Missoula MT 59812 USA
- 75N93023C00046 - 9447659.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
UNIVERSITY OF MARYLAND, BALTIMORE Baltimore MD 21201 USA
- W912HQ23C0072 - 1507529.00
SERDP PROJECT ER23-3683 PFAS TRANSPORT AND INTERACTION WITH PORTLAND CEMENT AND ASPHALT CONCRETE: A FIELD AND LABORATORY STUDY
North Carolina State University Raleigh NC 27607 USA
- 75N93023C00045 - 9274255.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
Administrators of the Tulane Educational Fund, The New Orleans LA 70118 USA
- 75N93023C00044 - 10527818.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
UNIVERSITY OF CHICAGO, THE Chicago IL 60637 USA
- 75N93023C00043 - 11012441.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
UNIVERSITY OF CALIFORNIA, SAN DIEGO La Jolla CA 92093 USA
- 75N93023C00042 - 9467715.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
INIMMUNE CORP Missoula MT 59802 USA
- 75N93023C00041 - 6450469.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
Trustees Of Columbia University In The City Of New York, The New York NY 10032 USA
- 75N93023C00040 - 8990145.00
NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES
Children's Hospital Corporation, d/b/a Boston Children's Hospital Boston MA 02115 USA
| This Issue's Index | Today's SAM Daily Index Page |
Created on 13-Sep-2023 by Loren Data Corp. -- info@samdaily.us